DoMore Diagnostics has obtained the CE mark for its Histotype Px Colorectal deep-learning algorithm to predict colorectal cancer patient outcomes based on the analysis of digital histology images, enabling its clinical use in the European Union and other geographies that accept the designation.

On May 23, New Horizon Health (6606.HK) and Prenetics Group Limited (NASDAQ: PRE, Prenetics for short) jointly announced a strategic cooperation to promote the listing of cancer early screening product ColoClear in Hong Kong and "going overseas" to Southeast Asia.

Freenome has initiated a clinical study tohelp bring an AI-Genomics blood test for colorectal cancer to the U.S. market. Freenome is looking to build a diagnostictest that can learn from its mistakes. The South San Francisco, CA- basedcompa